The All India Institute of Medical Sciences (AIIMS) Delhi will on Monday start screening children for the clinical trials of Covaxin, the indigenous Covid-19 vaccine developed by Bharat Biotech and ICMR. AIIMS Delhi started the clinical trials of Covaxin on children after AIIMS Patna, which started the trials recently on children aged between 12 and 18 years. Watch the video.
Comments